Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice

被引:45
作者
Bour-Jordan, W [1 ]
Thompson, HL [1 ]
Bluestone, JA [1 ]
机构
[1] Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA
关键词
D O I
10.4049/jimmunol.175.9.5649
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NOD mice deficient for the costimulatory molecule B7-2 (NOD-B7-2KO mice) are protected from autoimmune diabetes but develop a spontaneous autoimmune peripheral neuropathy that resembles human diseases Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Similar observations have now been made in conventional NOD mice. We have shown previously that this disease was mediated by autoreactive T cells inducing demyelination in the peripheral nervous system. In this study, we analyzed the molecular pathways involved in the disease. Our data showed that neuropathy developed in the absence of perforin or fas, suggesting that classic cytotoxicity pathways were dispensable for nerve damage in NOD-137-2KO mice. In contrast, IFN-gamma played an obligatory role in the development of neuropathy as demonstrated by the complete protection from disease and infiltration in the nerves in NOD-137-2KO mice deficient for IFN-gamma. This result was consistent with the inflammatory phenotype of T cells infiltrating the peripheral nerves. Importantly, the relative role of perforin, fas, and IFN-gamma appears completely different in autoimmune diabetes vs neuropathy. Thus, there are sharp contrasts in the pathogenesis of autoimmune diseases targeting different tissues in the same NOD background.
引用
收藏
页码:5649 / 5655
页数:7
相关论文
共 56 条
  • [41] Treatment of chronic inflammatory demyelinating polyneuropathy
    van Doorn, PA
    Ruts, L
    [J]. CURRENT OPINION IN NEUROLOGY, 2004, 17 (05) : 607 - 613
  • [42] Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet β-cell-reactive T-cells
    Vence, L
    Benoist, C
    Mathis, D
    [J]. DIABETES, 2004, 53 (11) : 2797 - 2803
  • [43] LYMPHOPROLIFERATION DISORDER IN MICE EXPLAINED BY DEFECTS IN FAS ANTIGEN THAT MEDIATES APOPTOSIS
    WATANABEFUKUNAGA, R
    BRANNAN, CI
    COPELAND, NG
    JENKINS, NA
    NAGATA, S
    [J]. NATURE, 1992, 356 (6367) : 314 - 317
  • [44] Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-α
    Weishaupt, A
    Brück, W
    Hartung, T
    Toyka, KV
    Gold, R
    [J]. NEUROSCIENCE LETTERS, 2001, 306 (1-2) : 77 - 80
  • [45] Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; Nonimmunized nonobese diabetic mice can develop autoimmune encephalitis
    Winer, S
    Astsaturov, I
    Cheung, RK
    Gunaratnam, L
    Kubiak, V
    Cortez, MA
    Moscarello, M
    O'Connor, PW
    McKerlie, C
    Becker, DJ
    Dosch, HM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (04) : 2831 - 2841
  • [46] Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive
    Winer, S
    Tsui, H
    Lau, A
    Song, AH
    Li, XM
    Cheung, RK
    Sampson, A
    Afifiyan, F
    Elford, A
    Jackowski, G
    Becker, DJ
    Santamaria, P
    Ohashi, P
    Dosch, HM
    [J]. NATURE MEDICINE, 2003, 9 (02) : 198 - 205
  • [47] Wohlleben G, 2000, GLIA, V30, P373, DOI 10.1002/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.3.CO
  • [48] 2-R
  • [49] Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen
    Yu, S
    Chen, ZG
    Mix, E
    Zhu, SW
    Winblad, B
    Ljunggren, HG
    Zhu, J
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (07) : 614 - 622
  • [50] In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat
    Zettl, UK
    Gold, R
    Toyka, KV
    Hartung, HP
    [J]. ACTA NEUROPATHOLOGICA, 1996, 91 (04) : 360 - 367